HETEROGENEOUS IMMUNOGLOBULIN GENE REARRANGEMENT IN A B-CHRONIC LYMPHOCYTIC-LEUKEMIA PROGRESSING INTO NON-HODGKIN LYMPHOMA (RICHTER SYNDROME)

被引:0
|
作者
KERIM, S
GEUNA, M
DICELLE, PF
CARBONE, A
PONTI, R
NOVERO, D
FOA, R
PALESTRO, G
机构
[1] UNIV TURIN,HUMAN ONCOL SECT,I-10126 TURIN,ITALY
[2] UNIV TURIN,PATHOL SECT,I-10126 TURIN,ITALY
[3] UNIV TURIN,CLIN SECT,I-10126 TURIN,ITALY
[4] UNIV TURIN,CNR,CTR IMMUNOGENET & HISTOCOMPATIBIL,I-10126 TURIN,ITALY
关键词
IMMUNOGLOBULIN REARRANGEMENT; MOLECULAR BIOLOGY; B-CHRONIC LYMPHOCYTIC LEUKEMIA; RICHTER SYNDROME;
D O I
10.1002/1097-0142(19930115)71:2<359::AID-CNCR2820710215>3.0.CO;2-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The relationship between chronic lymphocytic leukemia (CLL) and supervening non-Hodgkin lymphoma is debated, as is whether a particular genomic pattern is related to the emergence of the terminal lymphoma. To investigate these features, the molecular organization of the immunoglobulin (Ig) gene region in a case during both the B-CLL and Richter transformation phase was studied. Methods. B-CLL and non-Hodgkin lymphoma cells were processed for Southern blot analysis of Ig heavy-and light-chain gene configuration. Results. Molecular studies of B-CLL cells revealed the presence of a single Ig heavy-chain rearrangement with both kappa and lambda light-chain rearranged genes, which was consistent with the occurrence of multiple mutational events during the development of the B-CLL clone. Molecular analysis of the lymphoma DNA showed new Ig heavy- and kappa light-chain rearrangements in addition to the original ones related to the CLL phase, indicating that the lymphoma tissue consisted of two genotypically distinct populations of cells. Conclusions. On the basis of the overall molecular Configuration, this heterogeneous pattern of Ig gene rearrangement was interpreted as an inherent genetic instability of the CLL clone, in which multiple mutational events allowed a selective pressure toward more aggressive subclones, resulting in the emergence of the terminal lymphoma.
引用
收藏
页码:359 / 363
页数:5
相关论文
共 50 条
  • [11] Spotlight on Rituximab in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
    Risto S. Cvetković
    Caroline M. Perry
    BioDrugs, 2006, 20 : 253 - 257
  • [12] Spotlight on rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia
    Cvetkovic, Risto S.
    Perry, Caroline M.
    BIODRUGS, 2006, 20 (04) : 253 - 257
  • [13] Role of allotransplantation for non-Hodgkin lymphoma and chronic lymphocytic leukemia
    Dreger, P.
    ANNALS OF ONCOLOGY, 2011, 22 : 36 - 39
  • [14] Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma
    Famenini, Shannon
    Martires, Kathryn J.
    Zhou, Hui
    Xavier, Marin F.
    Wu, Jashin J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (01) : 78 - 84
  • [15] LYMPHOCYTIC LYMPHOMA B-CHRONIC LYMPHOCYTIC-LEUKEMIA - AN IMMUNOHISTOPATHOLOGICAL STUDY OF PERIPHERAL-B LYMPHOCYTE NEOPLASIA
    SWERDLOW, SH
    MURRAY, LJ
    HABESHAW, JA
    STANSFELD, AG
    BRITISH JOURNAL OF CANCER, 1984, 50 (05) : 587 - 599
  • [16] B-CHRONIC LYMPHOCYTIC-LEUKEMIA IN LATVIA - EPIDEMIOLOGIC ASPECTS
    YAVORKOVSKY, LI
    TEREBKOVA, ZF
    NIKULSHIN, SV
    YAVORKOVSKY, LL
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1993, 51 (04) : 214 - 217
  • [17] FC-RECEPTORS, IMMUNOGLOBULIN-BINDING FACTORS AND B-CHRONIC LYMPHOCYTIC-LEUKEMIA
    FRIDMAN, WH
    MATHIOT, C
    MONTCUIT, J
    TEILLAUD, JL
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1988, 30 (5-6): : 311 - 315
  • [18] ENZYMES OF PURINE METABOLISM IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA
    VERTONGEN, F
    CAUCHIE, C
    COURTOIS, P
    FONDU, P
    MANDELBAUM, IM
    AMERICAN JOURNAL OF HEMATOLOGY, 1984, 17 (01) : 61 - 70
  • [19] MENINGEAL INVOLVEMENT IN A CASE OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA
    CAROTENUTO, M
    CASCAVILLA, N
    LADOGANA, S
    VALORI, VM
    HAEMATOLOGICA, 1984, 69 (06) : 701 - 706
  • [20] NEW TRENDS IN THE BIOLOGY OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA
    CALIGARISCAPPIO, F
    BERGUI, L
    TESIO, L
    HAEMATOLOGICA, 1986, 71 (02) : 91 - 94